American Management Association. (2001). 2001 AMA survey on workplace testing: Medical testing.New York: Author.
2.
AnnunenS., PaassiltaP., LohinivaJ., PeralaM., PihlajarnaaT., KarppinenJ., TervonenO., KragerH., LahdeS., VanharantaH., RyhanenL., GoringH.H., OttJ., ProckopD.J., & Ala-KokkoL. (1999). An allele of COL9A2 associated with intervertebral disk disease. Science, 285(5246), 409–412.
3.
AnsellS.M., AckermanM.J., BlackJ.L., RobertsL.R., & TefferiA. (2003). Primer on medical genomics: Part VI: Genomics and molecular genetics in clinical practice. Mayo Clinic Proceedings, 78, 307–317.
4.
BormP.J., & SchinsR.P. (2001). Genotype and phenotype in susceptibility to coal workers' pneumoconiosis: The use of cytokines in perspective. European Respiratory Journal, 32(Supp.), 127s–133s.
5.
BosronW., EhrigT., & LiT. (1993). Genetic factors in alcohol metabolism and alcoholism. Seminars in Liver Disease, 13(2), 126–135.
6.
ChiodiniB.D., & LewisC.M. (2003). Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1863–1868.
7.
ChizhikovV., ChikinaS., GasparianA., ZborovskayaI., SteshinaE., UngiadzeG., SamsonovaM., ChernyaevA., ChuchalinA., & TatosyanA. (2002). Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers. Oncogene, 21(15), 2398–2405.
8.
ChristianiD.C., SharpR.R., CollmanG.W., & SukW.A. (2001). Applying genomic technologies in environmental health research: Challenges and opportunities. Journal of Occupational & Environmental Medicine, 43(6), 526–533.
9.
ElkinP.L. (2003). Primer on medical genomics: Part V: Bioinformatics. Mayo Clinic Proceedings, 78(1), 57–64.
10.
EnsenauerR.E., ReinkeS.S., AckermanM.J., TesterD.J., WhitemanD.A., & TefferiA. (2003). Primer on medical genomics: Part VIII: Essentials of medical genetics for the practicing physician. Mayo Clinic Proceedings, 78, 846–857.
11.
GillilandF.D., HarmsH.J., CrowellR.E., LiY.F., WillinkR., & BelinskyS.A. (2002). Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Cancer Research, 62(8), 2248–2252.
12.
GrauC. (1996). Genetics of alcoholism: An international perspective. Alcoholism: Clinical & Experimental Research, 20(Supp. 8), 78A–81A.
HiguchiS. (1994). Polymorphisms of ethanol metabolizing enzyme genes and alcoholism. Alcohol & Alcoholism, 2(Supp.), 29–34.
15.
HiguchiS., MatsushitaS., MurayamaM., TakagiS., & HayashidaM. (1995). Alcohol and aldehyde dehydrogenase polymorphisms and the risk of alcoholism. American Journal of Psychiatry, 152(8), 1219–1221.
16.
HiroseT., KondoK., TakahashiY., IshikuraH., FujinoH., TsuyuguchiM., HashimotoM., YukoseT., MusaiK., KodamaT., & MondenY. (2002). Frequent microsatellite instability in lung cancer from chromate-exposed workers. Molecular Carcinogenesis, 33(3), 172–180.
17.
IrieM., AsamiS., NagataS., MiyataM., & KasaiH. (2001). Relationships between perceived workload, stress and oxidative DNA damage. International Archives of Occupational & Environmental Health, 74(2), 153–157.
18.
KonishiT., CalvilloM., LengA., FengJ., LeeT., LeeH., SmithJ.L., SialS.H., BermanN., FrenchS., EysseleinV., LinK.M., & WanY.J. (2003). The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Experimental & Molecular Pathology, 74(2), 183–189.
19.
KopelmanP.G. (2000). Obesity as a medical problem. Nature, 404, 635–643.
20.
LaffonB., PasaroE., & MendezJ. (2002). Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology, 171(2-3), 175–186.
21.
LiT., YinS., CrabbD., O'ConnorS., & RamchandaniV. (2001). Genetic and environmental influences on alcohol metabolism in humans. Alcoholism: Clinical & Experimental Research, 25(1), 136–144.
22.
LorentzC.P., WiebenE.D., TefferiA., WhitemanD.A., & DewaldG.W. (2002). Primer on medical genomics: Part I: History of genetics and sequencing of the human genome. Mayo Clinic Proceedings, 77(8), 773–782.
23.
LuJ., JinT., NordbergG., & NordbergM. (2001). Metallothionein gene expression in peripheral lymphocytes from cadmium exposed workers. Cell Stress and Chaperones, 6(2), 97–104.
24.
MappC.E. (2003). The role of genetic factors in occupational asthma. European Respiratory Journal, 22(1), 173–178.
25.
MappC.E., FryerA., De MarzoN., PozzatoV., PadoanM., BoschettoP., StrangeR.C., HemmingsenA., & SpiteriM.A. (2002). Glutathione-s-transferase GSTP1 is a susceptibility gene for occupational asthma by isocyanates. Journal of Allergy & Clinical Immunology, 109(5), 867–872.
26.
MochizukiH., KamakuraK., MasakiT., HirataA., TokudaT., YazakiM., MotoyoshiK., & IkedaS. (2001). Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant. Amyloid, 8(2), 105–110.
27.
MoonS., GilbertsonL., NishidaK., KnaubM., MuzzonigroT., RobbinsP.D., EvansC.H., & KangJ.D. (2000). Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine, 25(20), 2573–2579.
28.
OkumaM., MochidaJ., NishimuraK., SakabeK., & SeikiK. (2000). Reinsertion of stimulated nucleus pulposus cells retards intervertebral disc degeneration: An in vitro and in vivo experimental study. Journal of Orthopedic Research, 18(6), 988–997.
29.
PaassiltaP., LohinivaJ., GoringH., PeralaM., RainaS., KarppinenJ., HakalaM., PalmT., KrogerH., KaitilaI., VanharantaH., OttJ., & Ala-KokkoL. (2001). Identification of a novel common genetic risk factor for lumbar disk disease. JAMA, 285(14), 1843–1849.
30.
PaulR., HaydonR., ChengH., IshikawaS., NenadovichN., JiangW., ZhouL., BreyerB., FengT., GuptaP., HeT.C., & PhillipsF.M. (2003). Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine, 28(8), 755–763.
31.
PotockiL., ChenK., KoeuthT., KillianJ., IannacconeS., ShapiraS., KashorkC.D., SpikesA.S., ShafferL.G., & LupskiJ.R. (1999). DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. American Journal of Human Genetics, 64(2), 471–478.
32.
RicheldiL., KreissK., MrozM.M., ZhenB., TartoniP., & SaltiniC. (1997). Interaction of genetic and exposure factors in the prevalence of berylliosis. American Journal of Industrial Medicine, 32(4), 337–340.
33.
RicheldiL., SorrentinoR., & SaltiniC. (1993). HLA-DPB1 glutamate 69: A genetic marker of beryllium disease [Comment]. Science, 262(5131), 242–244.
34.
SaltiniC., AmicosanteM., FranchiA., LombardiG., & RicheldiL. (1998). Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model. European Respiratory Journal, 12(6), 1463–1475.
35.
SaltiniC., & RicheldiL. (1995). A genetic marker for chronic beryllium disease. Medicina del Lavoro, 86(3), 226–228.
36.
SchillA.L. (2000). Genetic information in the workplace: Implications for occupational health surveillance. AAOHN Journal, 48(2), 80–91.
37.
SchulteP.A., LomaxG.P., WardE.M., & ColliganM.J. (1999). Ethical issues in the use of genetic markers in occupational epidemiologic research. Journal of Occupational & Environmental Medicine, 41(8), 639–646.
38.
SegalB. (1999). ADH and ALDH polymorphisms among Alaska Natives entering treatment for alcoholism. Alaska Medicine, 41(1), 9–12.
39.
ShaughnessyJ. (2003). Primer on medical genomics: Part IX: Scientific and clinical applications of DNA microarrays—Multiple myeloma as a disease model. Mayo Clinic Proceedings, 78, 1098–1109.
40.
ShieldsP.G., & HarrisC.C. (2000). Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. Journal of Clinical Oncology, 18(11), 2309–2315.
TakeshitaT. (1999). Genetic factors which regulate alcohol drinking behavior and their effects on health status. Nippon Eiseigaku Zasshi—Japanese Journal of Hygiene, 54(2), 450–458.
43.
TakeshitaT. (2003). Gene-environmental interactions in alcohol-related health problems—Contributions of molecular biology to behavior modifications. Nippon Eiseigaku Zasshi—Japanese Journal of Hygiene, 58(2), 254–259.
44.
TaylorA. (2001). Role of leukocyte antigen phenotype and exposure in development of occupational asthma. Current Opinion in Allergy & Clinical Immunology, 1(2), 157–161.
45.
TefferiA., BolanderM.E., AnsellS.M., WiebenE.D., & SpelsbergT.C. (2002). Primer on medical genetics: Part III: Microarray experiments and data analysis. Mayo Clinic Proceedings, 77, 927–940.
46.
TefferiA., WiebenE.D., DewaldG.W., WhitemanD.A., BernardM.E., & SpelsbergT.C. (2002). Primer of medical genomics: Part II: Background principles and methods in molecular genetics. Mayo Clinic Proceedings, 77(8), 785–808.
VidemanT., LeppavuoriJ., KaprioJ., BattieM.C., GibbonsL.E., PeltonenK., & KoskenvuoM. (1998). Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine, 23, 2477–2485.
49.
WallT., CarrL., & EhlersC. (2003). Protective association of genetic variation in alcohol dehydrogenase with alcohol dependence in Native American Mission Indians. American Journal of Psychiatry, 160(1), 41–46.
50.
WallT., Garcia-AndradeC., ThomassonH., CarrL., & EhlersC. (1997). Alcoholdehyrogenase polymorphisms in Native Americans: Identification of the ADH2*3 allele. Alcohol & Alcoholism, 32(2), 129–132.
51.
ZimmetP., AlbertiK.G., & ShawJ. (2001). Global and societal implications of the diabetes epidemic. Nature, 44, 782–787.
52.
ZolyomiZ., BensonM., HalaszK., UemichiT., & FeketeG. (1998). Transthyretin mutation (serine 84) associated with familial amyloid polyneuropathy in a Hungarian family. Amyloid, 5(1), 30–34.